After crossing the postoperative recovery, targeted two mountains, experts teach you to win this anti -cancer war!

According to the National Health and Health Commission's survey, the five -year survival rate of malignant tumors in my country has increased from 30.9%10 years ago to 40.5%, an increase of nearly 10 percentage points [1].

This is a pleasing number. With the implementation of the diversified treatment strategies of chemotherapy, radiotherapy, surgery, targeted and immunotherapy, in the field of lung cancer, the long -term survival of patients with advanced non -small cell lung cancer is no longer out of reach.

However, there are still two mountains on the road of anti -cancer, affecting the survival quality and survival of most patients with lung cancer -postoperative complications and targeted drug resistance.

01

Postoperative complications this mountain

The staging is early, and the surgical resection tumor can greatly improve the cure rate. Generally speaking, the earlier lung cancer, the higher the cure rate, the highest survival rate of 5 years can reach 92%[2].

Picture source: reference [2]

Although there is such a high cure, 8%-35%of patients will still encounter complications after surgery [3], common: respiratory complications (no lungs and obstructive lung swelling), lung infection , Bronchial pleural fistula, lightly affects the quality of life, and threatens life safety.

In addition to postoperative complications, some patients with lung cancer will also "meet the narrow road" with the targeted drug -resistant mountain in the treatment!

02

Objective to resist this mountain

In the past, some patients with lung cancer would think that if there is a medicine in the world and take it once or twice a day, it can control the disease, like hypertension or diabetes, how good it should be.

Now this idea has been achieved through a targeted drugs in some patients with lung cancer: taking medicine regularly every day can control the condition.

The emergence of targeted drugs has improved the quality of survival of patients, and also extended the patient's survival. However, during taking targeting medicines, patients will inevitably encounter some problems, such as:

Can I still take other targeted medicines when I have been resistant? Is there any other treatment if you can't target the treatment? Is it not so good for survival and quality of survival with other treatment methods?

03

Experts live broadcast to help anti -cancer

In order to help you solve the confusion and remove the fog of anti -cancer, under the guidance of the Chinese Anti -Cancer Association Popular Science Professional Committee, Fang Jianfeng Xiaofan opened the third theme of the 2022 "Lung Fan Power" in 2022. ! How can lung cancer cross the science popularization live broadcast of postoperative recovery and targeting the two mountains of drug resistance. "

In this live broadcast, we are very honored to invite three lung cancer experts: Professor Ouyang Weiwei from the Department of chest oncology at the Cancer Hospital Affiliated to Guizhou Medical University, Professor Song Yongxiang from the Department of chest surgery from the Affiliated Hospital of Zunyi Medical University and the elderly from the Cancer Hospital Affiliated to Chongqing University Professor Wang Sixiong of the Department of Oncology.

Live theme

In this live broadcast, Professor Song Yongxiang will discuss the treatment of postponed complications after lung cancer in detail; Professor Ouyang Weiwei and Professor Wang Sixiong will also answer questions about the two themes. What to do after medicine, the knowledge of lung cancer disease and diagnosis and treatment.

Live information

Live broadcast time

17: 00-19: 00 on August 18th

Live appointment

Pay attention to the popular science platform of the China Anti -Cancer Association, and make a wonderful live broadcast

Expert Introduction

Professor Ouyang Weiwei

Director of the Department of chest oncology at the Cancer Hospital of Guizhou Medical University

Member of the Fifth Tumor Biological Treatment Professional Committee of China Anti -Cancer Association

Cancer rehabilitation and palliative treatment professional committee of China Anti -Cancer Association

The first youth member of the Professional Committee of the China Anti -Cancer Association

Executive Member of the Radiation Treatment Committee of the Senior Cancer Professional Committee of the Chinese Society

Member of the Biology Group of Radiation Tumor Treatment Branch of the Chinese Medical Association

Youth Member of the Chinese Medical Association Radiation Tumor Treatment Branch

The first member of the first session of the Chinese Medical Doctors Association of Radi Therapist Branch

The first committee member of the Heating Professional Committee of the Chinese Medical Association Radious Tumor Treatment Medicine Branch

The second director of the Western Radiation therapy Association

Standing Member of the First Youth Committee of the Western Radiation therapy Association

Member of the Western Radiation Treatment Association's chest tumor radiation therapy special committee

Member of the Professional Committee of Lung Cancer Professional Committee of Southern China Cancer Clinical Research Association

Deputy Chairman of the Guizhou Pharmaceutical Association Pharmaceutical Clinical Experimental Committee

It is the editorial board of "Practical Cancer Magazine"

Professor Song Yongxiang

Director of Chemical Surgery at Zunyi Medical University Affiliated Hospital

Deputy Chairman of the Guizhou Anti -Cancer Association Cancer Surgery Committee

Standing Committee and Secretary of the Guizhou Medical Association's chest, cardiovascular vascular surgery branch

Guizhou Medical Association's chest, cardiovascular vascular surgery branch

Deputy Director of Chiefs and Cardoscopy Medical Quality Control Center of Kuang, Cardoscopy and thoracoscopy in Guizhou Province

Member of the Expert Group of Hand Sweat Shan Diosis of the Chinese Physician Association

Executive Member of Wu Jieping Medical Fund

Director of the Quality Control Center of Zunyi City's chest and cardiovascular vascular surgery

Deputy Chairman of the Zunyi Medical Association's chest cardiovascular vascular branch branch

Executive Member of the Organ Transplant Branch of Zunyi Medical Association

Professor Wang Sixiong

Deputy Director of Elderly Cancer Department of Chongqing University Affiliated Oncology Hospital

Member of the Cancer Nutrition Professional Committee of China Anti -Cancer Association

Member of the Cancer Nutrition Professional Member of the China Anti -Cancer Association of Cancer Association

Member of the Chemotherapy Association of Chongqing Anti -Cancer Association

Teaching Secretary of the Internal Science Teaching and Research Office of Oncology

Member of the Professional Committee of Tumor Drug Research of the Chinese Medicine Association of China

Member of the Professional Professional Member of the Medical Medical Professional Society of Chongqing Traditional Chinese and Western Medicine Society

Participate in 3 National Natural Science Foundation of China, presided over 1 key project of Chongqing Health and Health Commission, and won 1 item of the third prize of military science and technology progress.Treatment, especially tumor chemotherapy, biological immunotherapy, molecular targeted therapy, and standardized chemotherapy therapy for cancer pain

end

There is no magic in the world to cure cancer instantly,

Anti -cancer is a cycle of three steps forward and two steps.Although cancer divides our lives into two paragraphs. Before suffering from cancer, after suffering from cancer, this boundary is gradually blurred after overcoming fear and learning anti -cancer knowledge.

This is a relay of life. No matter where the end is, as long as there is hope, please continue to run!

- END -